Apelin is a new hormone that has been identified recently and its role in molecular changes is associated with type 2 diabetes, obesity, and cardiovascular disorders (Kleinz et al., 2005). This evidence concerns the gene APLN and obesity due to melanocortin 4 receptor deficiency.